Vocal Cord Dysfunction: Rapid Evidence Review

John Malaty, MD
Velyn Wu, MD

American Family Physician. 2021;104(5):471-475.

Author disclosure: No relevant financial affiliations.

Patient information: See related handout on vocal cord dysfunction.

Vocal cord dysfunction (i.e., vocal cords closing when they should be opening, particularly during inspiration) should be suspected in patients presenting with inspiratory stridor or wheezing; sudden, severe dyspnea (without hypoxia, tachypnea, or increased work of breathing); throat or chest tightness; and anxiety, particularly in females. Common triggers include exercise, asthma, gastroesophageal reflux disease, postnasal drip, upper or lower respiratory tract infection, and irritants. Nasolaryngoscopy and pulmonary function testing, with provocative exercise and methacholine, can help diagnose vocal cord dysfunction and are helpful to evaluate for other etiologies. Conditions that can trigger vocal cord dysfunction should be optimally treated, particularly asthma, gastroesophageal reflux disease, and postnasal drip, while avoiding potential irritants. Therapeutic breathing maneuvers and vocal cord relaxation techniques are first-line therapy for dyspnea that occurs with vocal cord dysfunction. A subset of vocal cord dysfunction leads to dysphonia, as opposed to dyspnea, secondary to abnormal laryngeal muscle spasms (vocal cord closure is less severe). OnabotulinumtoxinA injections may be helpful for spasmodic dysphonia and for treating dyspnea in certain cases, although evidence is limited.

Vocal cord dysfunction is a condition in which the vocal cords close when they should be opening, particularly during inspiration. This can be more severe and impair breathing or, more commonly, less severe and impact the patient's voice. This article is a brief summary and review of the best available evidence for the presentation, diagnosis, and management of vocal cord dysfunction.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

Epidemiology

  • Vocal cord dysfunction predominantly occurs in females (prevalence is two to three times greater in females than in males).1,2
  • It occurs at any age but is more commonly diagnosed in patients 30 to 40 years of age.1
  • It may coexist with asthma (25% to 30%),3,4 gastroesophageal reflux disease, or anxiety disorders.1,47
  • Vocal cord dysfunction is categorized as inducible laryngeal obstruction and is known by many other names,2,810 which are listed in Table 1.8

TABLE 1. Other Terms Used to Describe Vocal Cord Dysfunction

Emotional laryngeal asthma
Episodic laryngeal dyskinesia
Exercise-induced dyspnea
Factitious asthma
Functional dysphonia
Inducible laryngeal obstruction
Irritable larynx syndrome
Laryngospasm
Munchausen stridor
Paradoxical vocal cord dysfunction
Paradoxical vocal fold motion
Psychosomatic stridor
Spasmodic dysphonia

Information from reference 8.

Diagnosis

  • Vocal cord dysfunction should be considered in patients with poor response to optimal medical management of asthma or in those who have sudden, severe dyspnea without hypoxia, tachypnea, or increased work of breathing.1,47,1113
  • The differential diagnosis includes poorly controlled asthma, anatomic defects, laryngeal edema, nerve injury, and neurologic disorders11 (Table 2).
  • A suggested approach to the diagnosis of vocal cord dysfunction includes obtaining a clinical history focusing on triggers (Table 3) and symptoms, physical examination focusing on location and timing of stridor or wheezing, pulmonary function testing, and direct nasolaryngoscopy performed during an episode.1,47

TABLE 2. Differential Diagnosis of Vocal Cord Dysfunction

Amyotrophic lateral sclerosis
Anaphylaxis
Anatomic defects (laryngomalacia, subglottic stenosis, tracheal masses, vocal cord polyps)
Foreign body
Laryngeal edema (croup, epiglottitis)
Poorly controlled asthma
Vagus or recurrent laryngeal nerve injury

TABLE 3. Reported Triggers for Episodes of Vocal Cord Dysfunction

Exercise
Inflammatory states
 Asthma
 Episodic croup
 Gastroesophageal reflux disease
 Postnasal drip
 Recent upper or lower respiratory tract infection
Irritants
 Dry, cold air
 Toxin inhalation
 Workplace chemicals
Postoperative injury (with vocal cord paresis)
Psychiatric conditions
 Generalized anxiety disorder
 Major depression
 Obsessive-compulsive disorder
 Performance stress/anxiety

SIGNS AND SYMPTOMS

  • Many symptoms are a result of difficulty with breathing in air due to inappropriate closure of the vocal cords during inspiration. These symptoms include: Inspiratory stridor11

Wheezing, predominantly over the upper airway11

Severe, sudden dyspnea without oxygen desaturation, tachypnea, or increased work of breathing; often associated with anxiety1113

Chest or throat tightness12

Chronic cough may be an associated condition, although it typically does not occur during symptoms related to vocal cord dysfunction14

Onset with exposure to known triggers (Table 3)

  • When the vocal cord closure is less severe (from abnormal laryngeal muscle spasm), it impacts the voice, but not breathing, causing dysphonia or aphonia.15

DIAGNOSTIC TESTING

  • The diagnostic standard is direct visualization of vocal cord adduction during inspiration using nasolaryngoscopy.7 Diagnostic yield of nasolaryngoscopy is improved when the patient is experiencing symptoms and with provocation, such as exercise or use of methacholine.35,1115 Based on expert opinion, nasolaryngoscopy should be performed when signs and symptoms suggest vocal cord dysfunction.
  • In patients with vocal cord dysfunction, pulmonary function testing may show a flattened inspiratory flow loop or FEF50/FIF50 (ratio of expiratory flow to inspiratory flow at 50% of forced vital capacity) of 1 or greater.6,7,11 Yield is higher when the patient is experiencing symptoms.6 Use of methacholine during pulmonary function testing helps evaluate for asthma as an alternative diagnosis.7,1620
  • Pulmonary function testing should be performed when signs and symptoms suggest vocal cord dysfunction or when asthma is considered as a possible etiology.
  • If asthma is being considered, initial pulmonary function testing should be ordered before flexible nasolaryngoscopy. However, if asthma is unlikely, flexible nasolaryngoscopy should be used for the initial evaluation based on expert opinion.
  • Chest radiography may be considered to evaluate for other etiologies, such as a compressive mass, although vocal cord dysfunction tends to cause more intermittent symptoms.
  • Reviewing a patient-generated video of an acute, symptomatic episode can be helpful to assess signs and symptoms.

Treatment

ACUTE ATTACKS

  • Therapeutic breathing maneuvers and vocal cord relaxation techniques (see examples at https://www.youtube.com/watch?v=cKHd935oRBg) are recommended based on expert opinion, in the absence of clinical trials.13,17,21,22
  • Coexisting asthma should be treated with usual asthma care.
  • Heliox (a mixture of helium and oxygen) has been described as a potential treatment, but evidence is lacking.23

CHRONIC MANAGEMENT

  • There are no randomized trials to guide selection of therapy, which is largely based on expert opinion and pathophysiologic reasoning.
  • Therapeutic breathing maneuvers and vocal cord relaxation techniques are first-line therapy for dyspnea that occurs with vocal cord dysfunction.13,17,21,22,24 A single case study suggests that using aerodynamic feedback (real-time display of air flow and pressure changes during exhalation and phonation) can be helpful in learning breathing maneuvers.25 Speech therapy teaches these techniques.
  • A systematic review of six small, mostly poor-quality randomized controlled trials with 163 participants showed that speech therapy, including direct voice therapy and indirect voice therapy (education and counseling), improved voice in the treatment of functional dysphonia.26
  • Coexisting asthma, gastroesophageal reflux disease, and postnasal drip should be treated. Treating comorbid psychiatric conditions may be helpful for vocal cord dysfunction, but data are conflicting and limited.1,47,27
  • Based on guidelines from the American Academy of Otolaryngology–Head and Neck Surgery, onabotulinumtoxinA (Botox) injections into the laryngeal muscles may be used for the treatment of spasmodic dysphonia.28 These injections may be helpful in vocal cord dysfunction with dyspnea or concomitant asthma that is resistant to optimized asthma treatment, but evidence is limited.14,26,2830
  • Patients should avoid triggers, including irritants (Table 3).
  • Behavioral counseling should be considered for patients with comorbid anxiety and depression.27

REFERRAL

  • Referral to an ears, nose, and throat specialist should be considered for further evaluation (with nasolaryngoscopy) and management.
  • Referral to a speech therapist should be considered for therapeutic breathing maneuvers, vocal cord relaxation techniques, and speech therapy (initial management).

Prognosis

  • A small cohort study found that a multidisciplinary treatment approach for vocal cord dysfunction was associated with 57% fewer emergency department visits and/or hospital admissions and 52% fewer ambulatory clinic visits.31
  • Other small case series have reported that appropriate diagnosis and treatment result in symptom improvement and decreased use of asthma medications, although there were no comparison groups.3234

This article updates a previous article on this topic by Deckert and Deckert.35

Data Sources: A PubMed search was conducted using the terms vocal cord dysfunction, laryngospasm, paradoxical vocal fold motion, paradoxical vocal cord dysfunction, spasmodic dysphonia, episodic laryngeal dyskinesia, exercise induced dyspnea, inducible laryngeal obstruction, irritable larynx syndrome, emotional laryngeal asthma, factitious asthma, functional dysphonia, Munchausen stridor, and psychomotor stridor combined with the terms diagnosis, management, and treatment. These terms were also used to search the Agency for Healthcare Research and Quality, Essential Evidence Plus, and the Cochrane Database of Systematic Reviews. Search dates: October 15 to 17, 2020.

JOHN MALATY, MD, FAAFP, is an associate professor in the Department of Community Health and Family Medicine at the University of Florida, Gainesville, where he is medical director of the Main Street Clinic, associate program director of the Family Medicine Residency Program, and director of the Resident as Teacher Program.

VELYN WU, MD, FAAFP, CAQSM, is an assistant clinical professor in the Department of Community Health and Family Medicine at the University of Florida, where she is associate program director of the Family Medicine Residency Program.

Address correspondence to John Malaty, MD, FAAFP, University of Florida, 1707 N. Main St., Gainesville, FL 32609 (email: malaty@ufl.edu). Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

  1. 1.Li RC, Singh U, Windom HP, et al. Clinical associations in the diagnosis of vocal cord dysfunction. Ann Allergy Asthma Immunol. 2016;117(4):354-358.
  2. 2.Idrees M, FitzGerald JM. Vocal cord dysfunction in bronchial asthma. A review article. J Asthma. 2015;52(4):327-335.
  3. 3.Petrov AA. Vocal cord dysfunction: the spectrum across the ages. Immunol Allergy Clin North Am. 2019;39(4):547-560.
  4. 4.Lee JH, An J, Won HK, et al. Prevalence and impact of comorbid laryngeal dysfunction in asthma: a systematic review and meta-analysis. J Allergy Clin Immunol. 2020;145(4):1165-1173.
  5. 5.Cristel RT, Russell PT, Sims HS. Trauma-informed care improves management of paradoxical vocal fold movement patients. Laryngoscope. 2020;130(6):1508-1513.
  6. 6.Taramarcaz P, Seebach JD, Motteli L, et al. Spirometry and provocation tests for vocal fold dysfunction diagnosis: a retrospective case series. Swiss Med Wkly. 2019;148:w14692.
  7. 7.Shay EO, Sayad E, Milstein CF. Exercise-induced laryngeal obstruction (EILO) in children and young adults: from referral to diagnosis. Laryngoscope. 2020;130(6):E400-E406.
  8. 8.Christensen PM, Heimdal JH, Christopher KL, et al.; ERS/ELS/ACCP Task Force on Inducible Laryngeal Obstructions. ERS/ELS/ACCP 2013 international consensus conference nomenclature on inducible laryngeal obstructions. Eur Respir Rev. 2015;24(137):445-450.
  9. 9.Dunn NM, Katial RK, Hoyte FCL. Vocal cord dysfunction: a review. Asthma Res Pract. 2015;1:9.
  10. 10.Halvorsen T, Walsted ES, Bucca C, et al. Inducible laryngeal obstruction: an official joint European Respiratory Society and European Laryngological Society statement. Eur Respir J. 2017;50(3):1602221.
  11. 11.Pinto LHE, Aun MV, Cukier-Blaj S, et al. Vocal cord dysfunction diagnosis may be improved by a screening check list. Allergol Int. 2016;65(2):180-185.
  12. 12.Nolan PK, Chrysler M, Phillips G, et al. Pulse oximetry coupled with spirometry in the emergency department helps differentiate an asthma exacerbation from possible vocal cord dysfunction. Pediatr Pulmonol. 2007;42(7):605-609.
  13. 13.Ophir D, Katz Y, Tavori I, et al. Functional upper airway obstruction in adolescents. Arch Otolaryngol Head Neck Surg. 1990;116(10):1208-1209.
  14. 14.Vertigan AE, Kapela SL, Gibson PG. Chronic cough in vocal cord dysfunction: description of a clinical entity. Respir Med. 2020;168:105990.
  15. 15.Baxter M, Uddin N, Raghav S, et al. Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management. Respirology. 2014;19(4):531-537.
  16. 16.Tervonen H, Niskanen MM, Sovijärvi AR, et al. Fiberoptic videolaryngoscopy during bicycle ergometry: a diagnostic tool for exercise-induced vocal cord dysfunction. Laryngoscope. 2009;119(9):1776-1780.
  17. 17.Marcinow AM, Thompson J, Chiang T, et al. Paradoxical vocal fold motion disorder in the elite athlete: experience at a large division I university. Laryngoscope. 2014;124(6):1425-1430.
  18. 18.Shembel AC, Hartnick CJ, Bunting G, et al. Perceptual clinical features in exercise-induced laryngeal obstruction (EILO): toward improved diagnostic approaches. J Voice. 2019;33(6):880-893.
  19. 19.Guss J, Mirza N. Methacholine challenge testing in the diagnosis of paradoxical vocal fold motion. Laryngoscope. 2006;116(9):1558-1561.
  20. 20.Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest. 2002;122(6):1988-1993.
  21. 21.Johnston KL, Bradford H, Hodges H, et al. The Olin EILOBI breathing techniques: description and initial case series of novel respiratory retraining strategies for athletes with exercise-induced laryngeal obstruction. J Voice. 2018;32(6):698-704.
  22. 22.Rameau A, Foltz RS, Wagner K, et al. Multidisciplinary approach to vocal cord dysfunction diagnosis and treatment in one session: a single institutional outcome study. Int J Pediatr Otorhinolaryngol. 2012;76(1):31-35.
  23. 23.Slinger C, Slinger R, Vyas A, et al. Heliox for inducible laryngeal obstruction (vocal cord dysfunction): a systematic literature review. Laryngoscope Investig Otolaryngol. 2019;4(2):255-258.
  24. 24.Patel RR, Venediktov R, Schooling T, et al. Evidence-based systematic review: effects of speech-language pathology treatment for individuals with paradoxical vocal fold motion. Am J Speech Lang Pathol. 2015;24(3):566-584.
  25. 25.Carroll LM, Tan M. Aerodynamic measures and biofeedback as management in persistent paradoxical vocal fold motion and reverse phonation. J Voice. 2015;29(2):218-222.
  26. 26.Ruotsalainen JH, Sellman J, Lehto L, et al. Interventions for treating functional dysphonia in adults. Cochrane Database Syst Rev. 2007;(3):CD006373.
  27. 27.Guglani L, Atkinson S, Hosanagar A, et al. A systematic review of psychological interventions for adult and pediatric patients with vocal cord dysfunction. Front Pediatr. 2014;2:82.
  28. 28.Stachler RJ, Francis DO, Schwartz SR, et al. Clinical practice guideline: hoarseness (dysphonia) (update) [published correction appears in Otolaryngol Head Neck Surg. 2018;159(2):403]. Otolaryngol Head Neck Surg. 2018;158(1 suppl):S1-S42.
  29. 29.Watts C, Whurr R, Nye C. Botulinum toxin injections for the treatment of spasmodic dysphonia. Cochrane Database Syst Rev. 2004;(3):CD004327.
  30. 30.deSilva B, Crenshaw D, Matrka L, et al. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder. Laryngoscope. 2019;129(4):808-811.
  31. 31.Baxter M, Ruane L, Phyland D, et al. Multidisciplinary team clinic for vocal cord dysfunction directs therapy and significantly reduces healthcare utilization. Respirology. 2019;24(8):758-764.
  32. 32.George S, Suresh S. Vocal cord dysfunction: analysis of 27 cases and updated review of pathophysiology & management. Int Arch Otorhinolaryngol. 2019;23(2):125-130.
  33. 33.Yibrehu B, Georgakopoulos B, Mudd PA, et al. Outcomes of paradoxical vocal cord motion diagnosed in childhood. Ann Otol Rhinol Laryngol. 2020;129(12):1195-1209.
  34. 34.Kramer S, deSilva B, Forrest LA, et al. Does treatment of paradoxical vocal fold movement disorder decrease asthma medication use?. Laryngoscope. 2017;127(7):1531-1537.
  35. 35.Deckert J, Deckert L. Vocal cord dysfunction. Am Fam Physician. 2010;81(2):156-159. Accessed April 2, 2021. https://www.aafp.org/afp/2010/0115/p156.html

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.